Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely ... due diligence ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Enzymes catalyze cell reactions; coenzymes like CoQ10 are crucial for energy production and health, with potential genetic ...

"These results represent the first clinical evidence of in vivo CRISPR/Cas9 gene editing in cardiomyopathy ... a history of ischemic heart disease, in addition to ATTR-CM," the authors said.

This self-helper virus is an inhibited version of ASFV which has been modified using CRISPR/Cas9 technology, a powerful gene-editing tool ... and treatments. In addition to Dr. Vashee, the study ...